Specialty Pharma Worries Could Be Bigger Than Valeant
March 18, 2016 at 11:17 AM EDT
Analysts at Bernstein have warned that the payer pressure discussed by Valeant Pharmaceuticals Intl Inc (NYSE: VRX) in its conference ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.